Clinical and Histological Features of a Group of Patients with Sporadic Non-A, Non-B Hepatitis

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1981 Oct 1

PMID 6796615

Citations 12

Authors

M Bamber

A K Murray

I V Weller

A Morelli

P J Scheuer

H C Thomas

S Sherlock

Affiliations

Soon will be listed here.

Abstract

Twelve serologically proven cases of non-A, non-B (NANB) hepatitis have been described. The clinical course was mild in 11 patients. One patient, however, presented in portal systemic encephalopathy and required steroid treatment. Nine of the 12 patients continued to exhibit raised transaminase (AST) activities six or more months after the onset of the acute hepatitis. In these immunoglobulin concentrations were normal and autoantibodies were not present in significant titre. Four patients had evidence of previous hepatitis B infection, suggesting that the route of transmission of NANB might be similar to that of hepatitis B virus. A further four patients gave a history which suggests a possible parenteral mode of transmission. Liver biopsies were carried out both in the acute (8 cases) and chronic (6 cases) phases of the disease. Histological findings in liver biopsies covered the whole spectrum of acute and chronic hepatitis and 1 patient had cirrhosis. One notable feature in these biopsies was the presence of fatty changes.

Citing Articles

Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact.

Elgretli W, Chen T, Kronfli N, Sebastiani G Biomedicines. 2023; 11(2).

PMID: 36830808 PMC: 9953247. DOI: 10.3390/biomedicines11020271.

Hepatitis C Virus Uses Host Lipids to Its Own Advantage.

Sidorkiewicz M Metabolites. 2021; 11(5).

PMID: 33925362 PMC: 8145847. DOI: 10.3390/metabo11050273.

Lipids and HCV.

Bassendine M, Sheridan D, Bridge S, Felmlee D, Neely R Semin Immunopathol. 2012; 35(1):87-100.

PMID: 23111699 DOI: 10.1007/s00281-012-0356-2.

Hepatitis C virus: a historical perspective.

Sherlock S Dig Dis Sci. 1996; 41(12 Suppl):3S-5S.

PMID: 9011474 DOI: 10.1007/BF02087871.

Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers.

Weller I, Cohn D, Sierralta A, Mitcheson M, Ross M, Montano L Gut. 1984; 25(4):417-23.

PMID: 6423458 PMC: 1432359. DOI: 10.1136/gut.25.4.417.

References

VILLAREJOS V, Visona K, Eduarte C, Provost P, HILLEMAN M . Evidence for viral hepatitis other than type A or type B among persons in Costa Rica. N Engl J Med. 1975; 293(26):1350-2. DOI: 10.1056/NEJM197512252932606. View

Alter H, Holland P, Morrow A, Purcell R, Feinstone S, Moritsugu Y . Clinical and serological analysis of transfusion-associated hepatitis. Lancet. 1975; 2(7940):838-41. DOI: 10.1016/s0140-6736(75)90234-2. View

Mosley J, Redeker A, Feinstone S, Purcell R . Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med. 1977; 296(2):75-8. DOI: 10.1056/NEJM197701132960204. View

Knodell R, CONRAD M, Ishak K . Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology. 1977; 72(5 Pt 1):902-9. View

Dienstag J, Alaama A, Mosley J, Redeker A, Purcell R . Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med. 1977; 87(1):1-6. DOI: 10.7326/0003-4819-87-1-1. View

. Acute and chronic hepatitis revisited. Review by an international group. Lancet. 1977; 2(8044):914-9. View

Shirachi R, Shiraishi H, Tateda A, Kikuchi K, Ishida N . Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis. Lancet. 1978; 2(8095):853-6. DOI: 10.1016/s0140-6736(78)91567-2. View

. Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Lancet. 1974; 1(7862):854-7. View

POULSEN H, Christoffersen P . Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Pathol Microbiol Scand. 1969; 76(3):383-90. DOI: 10.1111/j.1699-0463.1969.tb03269.x. View

10.

Wyke R, Tsiquaye K, Thornton A, White Y, Portmann B, Das P . Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet. 1979; 1(8115):520-4. DOI: 10.1016/s0140-6736(79)90945-0. View

11.

Tsiquaye K, Zuckerman A . New human hepatitis virus. Lancet. 1979; 1(8126):1135-6. DOI: 10.1016/s0140-6736(79)91808-7. View

12.

Berman M, Alter H, Ishak K, Purcell R, Jones E . The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med. 1979; 91(1):1-6. DOI: 10.7326/0003-4819-91-1-1. View

13.

Rakela J, Redeker A . Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology. 1979; 77(6):1200-2. View

14.

Omata M, Afroudakis A, Liew C, Ashcavai M, Peters R . Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg). Gastroenterology. 1978; 75(6):1003-9. View

15.

Mathiesen L, Skinoj P, Nielsen J, Purcell R, Wong D, Ranek L . Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut. 1980; 21(1):72-7. PMC: 1419573. DOI: 10.1136/gut.21.1.72. View

16.

Vitvitski L, Trepo C, Prince A, Brotman B . Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet. 1979; 2(8155):1263-7. DOI: 10.1016/s0140-6736(79)92280-3. View